Efficacy and safety of GLP-1 receptor agonists in patients with schizophrenia spectrum disorders treated with antipsychotics: a systematic review and meta-analysis

European Neuropsychopharmacology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles